Camp4 Therapeutics Poration Stock Today
| CAMP Stock | USD 5.26 0.26 5.20% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
CAMP4 THERAPEUTICS is selling at 5.26 as of the 24th of March 2025; that is 5.20% increase since the beginning of the trading day. The stock's last reported lowest price was 3.98. CAMP4 THERAPEUTICS has 49 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
IPO Date 11th of October 2024 | Category Healthcare |
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. The company has 20.16 M outstanding shares of which 359.72 K shares are currently shorted by private and institutional investors with about 3.48 trading days to cover. More on CAMP4 THERAPEUTICS PORATION
Moving against CAMP4 Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CAMP4 Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Joshua MandelBrehm | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Jakarta Stock Exchange, Information Technology, Communications Equipment, Communication Equipment, Technology (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCAMP4 THERAPEUTICS can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CAMP4 THERAPEUTICS's financial leverage. It provides some insight into what part of CAMP4 THERAPEUTICS's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CAMP4 THERAPEUTICS PORATION (CAMP) is traded on NASDAQ Exchange in USA. It is located in One Kendall Square, Cambridge, MA, United States, 02139 and employs 53 people. CAMP4 THERAPEUTICS is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 102.82 M. CAMP4 THERAPEUTICS conducts business under Communications Equipment sector and is part of Information Technology industry. The entity has 20.16 M outstanding shares of which 359.72 K shares are currently shorted by private and institutional investors with about 3.48 trading days to cover.
CAMP4 THERAPEUTICS PORATION currently holds about 47.72 M in cash with (44.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Check CAMP4 THERAPEUTICS Probability Of Bankruptcy
Ownership AllocationCAMP4 THERAPEUTICS holds a total of 20.16 Million outstanding shares. Over half of CAMP4 THERAPEUTICS's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check CAMP4 Ownership Details
CAMP4 THERAPEUTICS Historical Income Statement
CAMP4 Stock Against Markets
CAMP4 THERAPEUTICS Corporate Management
| Kelly Gold | Chief Officer | Profile | |
| John Partain | Interim Experience | Profile | |
| Erik Schulz | Interim Officer | Profile | |
| Christian Horne | Interim Sales | Profile | |
| Brett Jackson | Senior Logistics | Profile | |
| Mark Gaydos | Chief Officer | Profile |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.